Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction

Drahomira Springer1 / Eliska Potlukova2 / Zdenka Limanova2 / 1

1Institute of Clinical Biochemistry and Laboratory Medicine, First Faculty of Medicine Charles University and General University Hospital, Prague, Czech Republic

2Third Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine Charles University and General University Hospital, Prague, Czech Republic

Corresponding author: Prof. Tomas Zima, MD, Dr Sc Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, U Nemocnice 2 121 08, Prague 2, Czech Republic Phone: +420 224962841, Fax: +420 224962848

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 50, Issue 7, Pages 1211–1220, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/cclm-2011-0598, March 2012

Publication History

Received:
2011-08-31
Accepted:
2012-02-29
Published Online:
2012-03-22

Abstract

The aim of general maternal-foetal care is to ensure an uncomplicated birth of a healthy baby to a healthy mother. There is a large range of screening tests used during pregnancy: for gestational diabetes, infection, rhesus-D status, thyroid dysfunction, as well as other tests. An important part of prenatal care is the screening of major aneuploidies, primarily for Down’s syndrome. This screening is possible in either the first or second trimester, or in both. Management of this type of screening is very similar around the world. Hypothyroidism can affect the psychomotor development of the child. Thyroid-stimulating hormone (TSH), autoantibodies against thyroperoxidase (TPOAb), and free thyroxin (FT4) were determined within our group of 7530 pregnant women. Elevated concentrations of TSH were found in 5.1%, suppression was found in 2.9% and 11.5% were TPOAb positive. Either a familial or personal history of thyroid or autoimmune diseases was present in 58.3% of those women who tested positive on any thyroid test. At minimum, 40% of women TPOAb positive during pregnancy have some kind of thyroid disorders after delivery. These results support the efficacy of general thyroid function screening in early pregnancy, as well as the follow-up after delivery of those women who are positive.

Keywords: Down’s syndrome; prenatal screening; thyroid disease

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
T.P. Foley, J.J. Henry, L.F. Hofman, R.D. Thomas, J.S. Sanfilippo, and E.W. Naylor
Journal of Women's Health, 2013, Volume 22, Number 11, Page 991

Comments (0)

Please log in or register to comment.